Publikationen 2011-2015

Jain D, Weber G, Eberhard D, Mehana AE, Eglinger J, Welters A, Bartosinska B, Jeruschke K, Weiss J, Päth G, Ariga H, Seufert J, Lammert E. DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death. PLoS One. 2015 Sep 30; 10(9)

Marquard J, Otter S, Welters A, Stirban A, Fischer A, Eglinger J, Herebian D, Kletke O, Klemen MS, Stožer A, Wnendt S, Piemonti L, Köhler M, Ferrer J, Thorens B, Schliess F, Rupnik MS, Heise T, Berggren PO, Klöcker N, Meissner T, Mayatepek E, Eberhard D, Kragl M, Lammert E. Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.Nat Med. 2015 Apr; 21(4):363-72

Lecroisey C, Le Pétillon Y, Escriva H, Lammert E, Laudet V. Identification, evolution and expression of an insulin-like peptide in the cephalochordate Branchiostoma lanceolatum. PLoS One. 2015 Mar 16; 10(3)

In't Veld P, Lammert E.The dark side of islet vasculature. Diabetologia. 2015 Jan; 58(1):4-6

O'Neill KE, Thowfeequ S, Li WC, Eberhard D, Dutton JR, Tosh D, Slack JM. Hepatocyte-ductal transdifferentiation is mediated by reciprocal repression of SOX9 and C/EBPα. Cell Reprogram. 2014 Oct;16(5):314-23

Ikels K, Kuschel S, Fischer J, Kaisers W, Eberhard D, Rüther U. FTO is a relevant factor for the development of the metabolic syndrome in mice. PLoS One. 2014 Aug 21;9(8)

Neufeld S, Planas-Paz L, Lammert E. Blood and lymphatic vascular tube formation in mouse. Semin Cell Dev Biol. 2014 Jul;31:115-23

Planas-Paz L, Lammert E. Mechanosensing in developing lymphatic vessels. Adv Anat Embryol Cell Biol. 2014;214:23-40

Akinci E, Banga A, Tungatt K, Segal J, Eberhard D, Dutton JR, Slack JM. Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA. PLoS One. 2013 Nov 29;8(11)

Planas-Paz L, Lammert E. Mechanical forces in lymphatic vascular development and disease. Cell Mol Life Sci. 2013 Nov;70(22):4341-54

Jain R, Jain D, Liu Q, Bartosinska B, Wang J, Schumann D, Kauschke SG, Eickelmann P, Piemonti L, Gray NS, Lammert E. Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets. Diabetologia. 2013 Jun;56(6):1350-5

Marquard J, Welters A, Buschmann T, Barthlen W, Vogelgesang S, Klee D, Krausch M, Raffel A, Otter S, Piemonti L, Mayatepek E, Otonkoski T, Lammert E, Meissner T. Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma. Diabetologia. 2013 Jan;56(1):31-5

Kragl M, Roensch K, Nüsslein I, Tazaki A, Taniguchi Y, Tarui H, Hayashi T, Agata K, Tanaka EM. Muscle and connective tissue progenitor populations show distinct Twist1 and Twist3 expression profiles during axolotl limb regeneration. Dev Biol. 2013 Jan 1;373(1):196-204

Zeeb M, Axnick J, Planas-Paz L, Hartmann T, Strilic B, Lammert E. Pharmacological manipulation of blood and lymphatic vascularization in ex vivo-cultured mouse embryos. Nat Protoc. 2012 Nov;7(11):1970-82.

Kragl M, Lammert E. Calcineurin/NFATc signaling: role in postnatal β cell development and diabetes mellitus. Dev Cell. 2012 Jul 17;23(1)

Jain D, Jain R, Eberhard D, Eglinger J, Bugliani M, Piemonti L, Marchetti P, Lammert E. Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes J Mol Cell Biol. 2012 Aug;4(4):221-30

Axnick J, Lammert E. Vascular lumen formation. Curr Opin Hematol. 2012 May;19(3):192-8

Lammert E, Axnick J. Vascular lumen formation. Cold Spring Harb Perspect Med. 2012 Apr;2(4)

Planas-Paz L, Strilić B, Goedecke A, Breier G, Fässler R, Lammert E. Mechanoinduction of lymph vessel expansion.
EMBO J
. 2012 Feb 15;31(4):788-804

Bos FL, Caunt M, Peterson-Maduro J, Planas-Paz L, Kowalski J, Karpanen T, van Impel A, Tong R, Ernst JA, Korving J, van Es JH, Lammert E, Duckers HJ, Schulte-Merker S. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ Res. 2011 Aug 19;109(5):486-91

Bürgers AC, Lammert E. Extraerythrocytic hemoglobin--a possible oxygen transporter in human malignant tumors. Med Hypotheses. 2011 Oct;77(4):580-3

Verantwortlich für den Inhalt: E-Mail sendenProf. Dr. Eckhard Lammert